Clinical Research

Clinical Trials help Doctors understand how to treat a particular disease or condition. It may benefit you, or others like you, in the future.

If you take part in a Clinical Trial, you may be one of the first people to benefit from a new treatment.

We fully respect your confidentiality and will not share your medical information with any identifiable data (no names, full postcodes, NHS numbers or full dates of birth).

If you have requested that you data is not to be shared outside the practice then your information will not be included in these statistics – Please notify the Practice.

If you have any queries about this please ask to speak to the Practice Manager.

We have undertaken research over the years, but formally got involved in 2013 when we registered as a research ready practice with the RCGP.

Our practice lead for research is Dr Laloo, however all members of the staff are involved at some time or the other. We have taken part in a number of studies in the last few years eg CASPER, HEAT.

Current research projects

ECASS study

Evaluation of a Computer Aid for assessing Stomach Symptoms. This is a study to test the effects of a computerised clinical decision support (eCDS) tool to assist GPs in selection of patients for gastroscopy for possible OG cancer, and to collect all the relevant data to inform a phase III trial of such a tool.

Trial has now ended.

BARACK-D study

To investigate whether a tablet commonly used to treat raised blood pressure can be beneficial for people with chronic kidney disease (CKD) by reducing the onset of cardiovascular disease.


Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease

Allopurinol is a medication usually used to prevent gout. Allopurinol has several positive effects on the heart and blood vessels, is inexpensive and is already widely used in patients. Ischaemic heart disease is common in people in the UK. In this study, we want to improve the treatment of patients with ischaemic heart disease. We want to investigate whether adding allopurinol to these patients’ usual medications will reduce their risk of having a stroke, heart attack or of dying due to cardiovascular disease.

If you are interested in taking part in research or have any ideas please feel free to speak to us.